Jing An1, Weiwei Yao1, Waner Tang1, Jingjing Jiang1, Yu Shang1. 1. Institute of Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, P. R. China.
Abstract
Methyl triclosan (mTCS) is a methylated derivative of triclosan (TCS), which is extensively used as an antimicrobial component of various nursing products and disinfectants. Current research studies of mTCS mainly focused on the environmental persistence and bioaccumulation potential. Knowledge regarding the toxicity and carcinogenicity of mTCS is limited until now. In this study, the human hepatocyte L02 cells were used to investigate the cellular effects of mTCS under different concentrations (0.1-60 μM). The hormesis effect was observed where a low dose of mTCS (≤5 μM) exposure stimulated the cell proliferation ability, while high-dose exposure (≥20 μM) inhibited cell proliferation. In the same time, low doses of mTCS (0.5 and 1 μM) induced enhanced anchorage-independent proliferation ability and cell migration ability, indicating a positive effect on malignant transformation in L02 cells. Moreover, reactive oxygen species productions were significantly increased after mTCS exposure (≥1 μM), as compared with the control group. Furthermore, expressions of tumor-related genes, mouse double minute 2 (MDM2), matrix metalloproteinase 9 (MMP9), and proliferating cell nuclear antigen (PCNA), and proto-oncogene MYC (c-Myc), Jun, and FosB were significantly upregulated, while no significant changes were observed on expressions of apoptosis-related and cell cycle-related genes in L02 cells after exposure of low-dose mTCS. In conclusion, these results indicated that a low dose of mTCS had a hormesis effect in L02 cells on cell proliferation and malignant transformation in vitro, which might be mediated through oxidative stress response.
Methyl triclosan (mTCS) is a methylated derivative of triclosan (TCS), which is extensively used as an antimicrobial component of various nursing products and disinfectants. Current research studies of mTCS mainly focused on the environmental persistence and bioaccumulation potential. Knowledge regarding the toxicity and carcinogenicity of mTCS is limited until now. In this study, the human hepatocyte L02 cells were used to investigate the cellular effects of mTCS under different concentrations (0.1-60 μM). The hormesis effect was observed where a low dose of mTCS (≤5 μM) exposure stimulated the cell proliferation ability, while high-dose exposure (≥20 μM) inhibited cell proliferation. In the same time, low doses of mTCS (0.5 and 1 μM) induced enhanced anchorage-independent proliferation ability and cell migration ability, indicating a positive effect on malignant transformation in L02 cells. Moreover, reactive oxygen species productions were significantly increased after mTCS exposure (≥1 μM), as compared with the control group. Furthermore, expressions of tumor-related genes, mouse double minute 2 (MDM2), matrix metalloproteinase 9 (MMP9), and proliferating cell nuclear antigen (PCNA), and proto-oncogene MYC (c-Myc), Jun, and FosB were significantly upregulated, while no significant changes were observed on expressions of apoptosis-related and cell cycle-related genes in L02 cells after exposure of low-dose mTCS. In conclusion, these results indicated that a low dose of mTCS had a hormesis effect in L02 cells on cell proliferation and malignant transformation in vitro, which might be mediated through oxidative stress response.
Methyl triclosan (mTCS)
is a major biomethylation derivative of
the environmental contaminant triclosan (TCS), which is a broad-spectrum
antibacterial agent added to hand sanitizers, toothpastes, soaps,
and other daily chemical products for more than 40 years.[1] Generally, mTCS can be transformed by microorganisms
under aerobic conditions. Replacing the hydrogen in TCS with a methyl
group gives mTCS novel physicochemical properties including loss of
antibacterial properties, increased resistance to photodegradation,
environmental persistence, and longer half-life duration.[2,3] Furthermore, mTCS is more hydrophobic and lipophilic than TCS, resulting
in the widespread existence of mTCS in multiple environmental media
including water, soil, and estuarine sediment,[4] as well as in diverse organisms such as marine lives,[4] freshwater algae,[5] and earthworms.[6] It has been reported
that concentrations of mTCS in fish from lakes of Switzerland ranged
from 4 to 365 ng/g,[7] which were higher
than that of TCS. In the biotransformation of the river biofilm, the
concentration of mTCS and other biotransformation products reached
42% of the parental TCS level.[8] Balmer et al. suggested that mTCS could be used as a suitable marker
for wastewater treatment plant-derived prolipid contaminants in aquatic
environments.[7]Moreover, mTCS in
various organisms could be enriched into the
human body through foods such as eggs and milk.[9] Goodbred et al. first reported the biomagnification
capability of mTCS in the food network with a trophic amplification
factor of 3.85.[10] Until now, mTCS has been
detected in human blood, urine,[11] breast
milk, liver tissue, brain tissue, and other tissues,[12] which pose potential risks to human health. Moreover, increased
production and application of disinfectant products against the novel
coronavirus pneumonia had released more mTCS into the environmental
media,[13] making it urgent to promote the
investigation on the toxicology effects and regulating mechanisms
of mTCS.Toxicology research studies have reported that mTCS
induced embryonic
development toxicity in zebrafish, manifested as delay in development
of zebrafish (Danio rerio) embryo and
sea urchin larvae,[14] disruption of the
metabolomes, and dysregulation on the biological pathways including
nitrogen metabolism, energy metabolism, and fatty acid synthesis.[15,16] In addition, mTCS could influence the thyroid hormone-responsive
gene transcripts in rat pituitary GH3 cells, displaying the potential
endocrine disruption property.[17] Our preliminary
experimental data proved that mTCS could cause oxidative damage and
induce cell cycle arrest at the S phase and caspase-dependent mitochondrial
apoptosis in HepG2 cells.[18,19] Transcriptomic analysis
of HepG2 cells revealed that mTCS might cause various biological responses
including biosynthetic and metabolic processes and cellular organelle’s
function.[20] However, previous research
studies were mainly conducted on the related high concentration of
mTCS, while the toxicological effects and regulatory mechanism in
organisms of environmental-related concentration are still limited.Hormesis refers to a biphasic dose–response relationship
of the chemical characterized by adaptive and stimulating effects
at low doses.[21] Long-term exposure to low-dose
environmental stress triggers has been confirmed to be associated
with many chronic diseases.[22−24] Given the fact that current toxicology
experiments of mTCS were generally conducted on much higher concentrations
than environmental dose, the toxicity evaluation induced by environmental
relevant concentrations is of significance in formulating safety standards
for environmental pollutants. The results of Wang et al. displayed that low concentration of BDE-47 (10–10 to 10–8 M) induced the hormesis effect in HepG2
cells mediated with the DNA-dependent protein kinase catalytic subunit/phosphorylated
protein kinase B pathway.[25] The purpose
of this study was to confirm the hormesis effect of environmental
doses of mTCS in normal human liver cells and to explore the underlying
molecular mechanism. This research will provide experimental support
to formulate risk assessment and control policies for mTCS.
Results
and Discussion
Effect of mTCS on Cell Proliferation
It was reported
that both mTCS and TCS had toxic effects on embryo of sea urchin larvae,
and mTCS could more efficiently influence the larval length than TCS.[26] Gaume et al. investigated the
cell viability of abalone blood cells exposed to mTCS for 24 h, finding
that significant cytotoxicity was observed in mTCS-treated groups
over concentrations of 4 μM.[27] Our
previous data showed that mTCS had a toxic effect on liver cancer
cells HepG2, and the cell survival rate at 40 μM reduced to
91.5% compared to the control.[28] Considering
the environmental relevant mTCS concentration, as well as its low
degradation rate and bioaccumulation tendency, the present study performed
cell counting kit-8 (CCK-8) assay, plate cloning test, and soft agar
cloning experiment to evaluate the effects of mTCS on cell proliferation
of L02 under both low- and high-dose ranges.As shown in Figure A, the cell viability
after low-dose mTCS exposure (0.5, 1, and 5 μM) was slightly
increased, and the stimulating effect was most pronounced in the 1
μM group (Figure A, p < 0.05). Cell viability of L02 exposed to
a high dose of mTCS (20, 40, and 60 μM), however, was dose-dependently
reduced compared to the control (Figure A). The results of plate cloning experiments
displayed that low-dose mTCS (0.1, 0.5, 1, and 5 μM) stimulated
the clone formation rates of L02 cells. Consistently, the highest
clone formation rate was observed in the 1 μM mTCS group, with
a 15.3% increase over the control (Figure B, p < 0.01). Meanwhile,
there was a significant decrease in the clone formation rates observed
in the groups of 40 and 60 μM mTCS (p <
0.05). Subsequently, 0.5, 1, and 5 μM were selected as the representative
low-dose treatment groups for soft agar cloning experiment. The results
consistently showed a stimulating effect on soft agar clone formation,
which was also the most outstanding in the 1 μM mTCS group (Figure C,D, p < 0.05). In summary, the abovementioned experimental data indicated
that mTCS exposure had obvious hormesis effects on cell proliferation
of L02 cells.
Figure 1
Effect of mTCS exposure on cell proliferation of L02.
(A): L02
cells were treated with different concentrations of mTCS (0, 0.1,
0.5, 1, 5, 10, 20, 40, and 60 μM) for 48 h, and then,
the cell proliferation ability was determined by the CCK8 kit. (B):
L02 cells were treated with different concentrations of mTCS (0, 0.1,
0.5, 1, 5, 10, 20, 40, and 60 μM) for 14 d, and the plate
clone formation ability was assayed. (C) L02 cells were treated with
different concentrations of mTCS (0, 0.5, 1, and 5 μM)
for 14 d, and the soft agar cloning formation ability was analyzed.
(D): Representative images of soft agar cloning formation. A multiple
comparison adjustment was conducted to compare the difference between
groups, and the Bonferroni-corrected p-values less
than 0.05 were considered statistically significant. *p < 0.05 and **p < 0.01, compared with the
control group. C: control group: cells were treated with 0.1% dimethyl
sulfoxide (DMSO)/Dulbecco’s modified eagle’s medium
(DMEM) (v/v).
Effect of mTCS exposure on cell proliferation of L02.
(A): L02
cells were treated with different concentrations of mTCS (0, 0.1,
0.5, 1, 5, 10, 20, 40, and 60 μM) for 48 h, and then,
the cell proliferation ability was determined by the CCK8 kit. (B):
L02 cells were treated with different concentrations of mTCS (0, 0.1,
0.5, 1, 5, 10, 20, 40, and 60 μM) for 14 d, and the plate
clone formation ability was assayed. (C) L02 cells were treated with
different concentrations of mTCS (0, 0.5, 1, and 5 μM)
for 14 d, and the soft agar cloning formation ability was analyzed.
(D): Representative images of soft agar cloning formation. A multiple
comparison adjustment was conducted to compare the difference between
groups, and the Bonferroni-corrected p-values less
than 0.05 were considered statistically significant. *p < 0.05 and **p < 0.01, compared with the
control group. C: control group: cells were treated with 0.1% dimethyl
sulfoxide (DMSO)/Dulbecco’s modified eagle’s medium
(DMEM) (v/v).
Effect of mTCS Exposure
on the Cell Migration
Wound
healing assay is a simple and economical test to investigate the cell
migration capability in vitro, which could to some
extent mimic the process of cell migration in vivo. A 24 h exposure of benzo[a]pyrene (1 μM)
was reported to promote the migration capability of mouse hepatocarcinoma
cell line Hepa1-6 cells.[29] Furthermore,
a low dose of tetrabromobisphenol A and its derivatives can also trigger
the malignant migration in endometrial cancer cells.[30] As shown in Figure A,B, compared with the control group (0.1% DMSO), the healing
rate of scratch significantly increased in the low-dose mTCS treatment
groups (0.5, 1, and 5 μM). The 1 μM mTCS group showed
the highest healing rate, with a 113.7% increase over the control
group after 24 h exposure (p < 0.05). Nevertheless,
the healing rate of the 40 μM mTCS group was significantly lower
than the control group. These results indicated that mTCS exerted
a biphasic dose–response on wound healing, which is a stimulating
effect at low doses (0.5, 1, and 5 μM mTCS) and inhibiting effect
at high doses (40 μM mTCS). Thus, in the subsequent experiments,
1 μM mTCS was reserved as the representative adaptive dose and
40 μM mTCS was reserved as the inhibitory dose.
Figure 2
Effect of mTCS on cell
migration. (A) L02 cell was treated with
different concentrations of mTCS (0, 0.5, 1, 5, and 40 μM)
for 24 h/48 h, and then, the cell migration ability was determined
by wound healing assay. Images were captured with a microscope reader
(Olympus, Tokyo, Japan) under 10× objective lens. (B) Quantitated
data of the healing rate analyzed with ImageJ software. The Bonferroni-corrected p-values less than 0.05 among multiple comparisons were
considered statistically significant. *p < 0.05,
compared with the control group. (C) control group: cells were treated
with 0.1% DMSO/DMEM (v/v).
Effect of mTCS on cell
migration. (A) L02 cell was treated with
different concentrations of mTCS (0, 0.5, 1, 5, and 40 μM)
for 24 h/48 h, and then, the cell migration ability was determined
by wound healing assay. Images were captured with a microscope reader
(Olympus, Tokyo, Japan) under 10× objective lens. (B) Quantitated
data of the healing rate analyzed with ImageJ software. The Bonferroni-corrected p-values less than 0.05 among multiple comparisons were
considered statistically significant. *p < 0.05,
compared with the control group. (C) control group: cells were treated
with 0.1% DMSO/DMEM (v/v).
Oxidative Responses Induced by mTCS in L02 Cells
L02
cells were treated with different concentrations of mTCS (0.1, 0.5,
1, 5, 10, 20, and 40 μM) for 24 h, and then, the production
of reactive oxygen species (ROS) was detected with 2′,7′-dichlorodihydrofluorescein
diacetate (DCFH-DA) assay. As shown in Figure , the ROS levels in L02 cells after a short-term
mTCS exposure were significantly stimulated compared with the control
group, with 16, 34.5, 53.7, 80.1, 74.9, 101.1, and 151.9% increase.
ROS-mediated oxidative stress is associated with many processes, including
cell proliferation, DNA damage, apoptosis, cell cycle, and so on.[31] Generally, overproduction of ROS can inhibit
cell proliferation and induce DNA damage and cell death, which is
proved to be an important toxicological mechanism for many toxicants,
especially under high-dose exposure conditions.[32,33] On the other hand, some chemicals at low levels induced only slightly
increased ROS production, which can activate certain cytoprotective
pathways, such as the extracellular regulated protein kinase signaling
pathway, resulting in stimulatory effects on cell proliferation.[34,35] The persistent stimulation of cell proliferation induced by long-term
low-dose exposure was associated with the carcinogenic potential of
many pharmaceutical and environmental compounds.[36] In addition, Kasuba et al. found that
low-dose glyphosate exposure slightly stimulated the proliferation
of HepG2 cells, but there was no significant change in ROS production
levels due to activation of the antioxidant system, which can effectively
remove excess ROS produced during exposure.[37] In our study, combined with the results of cell proliferation assays,
the slightly increased ROS induced by low concentrations of mTCS triggered
adaptive cellular processes to protect cells against oxidative damages,
which may consequently result in enhanced cell proliferation.
Figure 3
Oxidative response
induced by mTCS exposure in L02 cells. The L02
cell was treated with different concentrations of mTCS (0.1, 0.5,
1, 5, 10, 20, and 40 μM) for 24 h, and then, the ROS
level was detected with the DCFH-DA probe. *p <
0.05 and **p < 0.01, compared with the control
group. C: control group: cells were treated with 0.1% DMSO/DMEM (v/v).
tBHP: tert-butyl hydroperoxide.
Oxidative response
induced by mTCS exposure in L02 cells. The L02
cell was treated with different concentrations of mTCS (0.1, 0.5,
1, 5, 10, 20, and 40 μM) for 24 h, and then, the ROS
level was detected with the DCFH-DA probe. *p <
0.05 and **p < 0.01, compared with the control
group. C: control group: cells were treated with 0.1% DMSO/DMEM (v/v).
tBHP: tert-butyl hydroperoxide.
Molecular Mechanism of the Hormesis Effect Induced by mTCS in
L02 Cells
Proto-oncogene MYC (c-Myc) and proliferating cell
nuclear antigen (PCNA) are widely recognized as cellular proliferation
markers.[38,39] Changes in the expression levels of these
genes are closely correlated with the cell proliferation capability.
Increased c-Myc expression level, together with overexpression of
PCNA, was associated with malignant transformation, tumor initiation,
promoted tumor progression, and poor prognosis in a variety of malignancies.[40−43] Mouse double minute 2 (MDM2) is an oncogenic protein and a negative
regulator of the tumor suppressor p53 protein.[44] Overexpression of MDM2 has been detected in many humanmalignancies, including lung cancer, colon cancer, and other malignancies.[45] Guan et al. found that knocking
down of MDM2 in osteosarcoma cells could significantly inhibit the
cell proliferation, migration, and invasion capability.[46] In this study, the mRNA expression levels of c-Myc, MDM2, and PCNA in
L02 cells were significantly upregulated in the low-dose groups compared
to the control, with a 36.7, 40.3, and 40.7% induction, respectively
(p < 0.05, Figure A). Furthermore, the protein expression of MDM2 was
also increased over 1.8-, 2.1-, and 1.8-fold after exposure of 0.5,
1, and 5 μM mTCS, respectively (Figure B,C). The abnormal expression of these genes
may partially explain the enhanced proliferation ability and malignant
transformation of L02 cells after low-dose mTCS exposure.
Figure 4
Effect of mTCS
on the expressions of c-Myc, MDM2, and PCNA in L02
cells. (A) L02 cell was treated with 1 μM mTCS for 12 h, and
then, the expressions of c-Myc, MDM2, and PCNA were determined by real time-quantitative
polymerase chain reaction (RT-qPCR). (B) L02 cell was treated with
0.5, 1, and 5 μM mTCS for 24 h, and then, the expression of
MDM2 protein was determined by western blotting. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression was used as the internal reference.
(C) Quantization results of protein expression levels of MDM2. *p < 0.05 and **p < 0.01, compared
with the control group. (C) Control group: cells were treated with
0.1% DMSO/DMEM (v/v).
Effect of mTCS
on the expressions of c-Myc, MDM2, and PCNA in L02
cells. (A) L02 cell was treated with 1 μM mTCS for 12 h, and
then, the expressions of c-Myc, MDM2, and PCNA were determined by real time-quantitative
polymerase chain reaction (RT-qPCR). (B) L02 cell was treated with
0.5, 1, and 5 μM mTCS for 24 h, and then, the expression of
MDM2 protein was determined by western blotting. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression was used as the internal reference.
(C) Quantization results of protein expression levels of MDM2. *p < 0.05 and **p < 0.01, compared
with the control group. (C) Control group: cells were treated with
0.1% DMSO/DMEM (v/v).Tumor-related gene matrix
metalloproteinase 9 (MMP9) is considered
as a prognostic marker during cancer progression, mediating cancer
cell invasion and metastasis.[47] Overexpression
of MMP9 was associated with enhanced migration of hepatocellular carcinoma
cells,[48] and downregulating the MMP2 and
MMP9 activity could suppress the cell migration capability.[49] Similarly, glioma-associated oncogene homolog
1 (GLI1) is highly expressed in human endometrial stromal cells. Reducing
the expression of GLI1 led to inhibition of MMP2 and MMP9 expression
and consequent attenuation of malignant migration, invasion, and proliferation.[50] In the present study, MMP9 expression levels
were over 1.5-, 2.3-, and 1.6-fold of that in the control group under
0.5, 1, and 5 μM mTCS exposure, respectively (Figure A,B), indicating that MMP9
participated in regulating the cell proliferation and migration induced
by mTCS.
Figure 5
Effect of mTCS on the expressions of MMP9 in L02 cells. (A) L02
cell was treated with 0.5, 1, and 5 μM mTCS for 24 h, and then,
the expression of MMP9 protein was determined by western blotting.
GAPDH protein expression was used as the internal reference. (B) Quantization
data of MMP9 protein expression levels. *p < 0.05
and **p < 0.01, compared with the control group.
(C) Control group: cells were treated with 0.1% DMSO/DMEM (v/v).
Effect of mTCS on the expressions of MMP9 in L02 cells. (A) L02
cell was treated with 0.5, 1, and 5 μM mTCS for 24 h, and then,
the expression of MMP9 protein was determined by western blotting.
GAPDH protein expression was used as the internal reference. (B) Quantization
data of MMP9 protein expression levels. *p < 0.05
and **p < 0.01, compared with the control group.
(C) Control group: cells were treated with 0.1% DMSO/DMEM (v/v).B-cell lymphoma 2 (BCL2)-associated X (BAX) and
caspase 3 are downstream
target genes of tumor protein p53, which plays an important role in
mitochondrial pathway apoptosis.[51] P53
inhibition in pancreatic cancer cells could enhance MDM2 expression
and reduce BAX, caspase 3, caspase 9, and cyclin-dependent kinase
inhibitor 1A (p21).[52] Bai et al. found that cytosine-phosphorothioate-guanine oligodeoxynucleotides
could induce apoptosis in humanbladder cancer cells by enhanced expressions
of pro-apoptotic-related factors caspase 3, BAX, and p53, as well
as reduced BCL2 expression.[53] Cytochrome c (Cyt-c) is one of the key mediators of
the mitochondrial-mediated endogenous apoptotic pathway, which can
be released from the mitochondria into the cytoplasm under oxidative
stress.[54,55] Li et al. found that the
expression levels of Cyt-c and caspase 3 in human
multiple myeloma cells exposed to zinc oxide nanoparticles were significantly
higher than those in the control group.[56] We previously found that a high dose of mTCS exposure resulted in
significantly increased ROS production, enhanced p53 and caspase 3 expression, and reduced MDM2 expression, indicating that high-dose mTCS could induce caspase-dependent
mitochondrial apoptosis in HepG2 cells.[28] However, in this study, the expressions of Cyt-c and caspase 3 in L02 cells exposed to a low dose
of mTCS was only slightly increased to levels comparable to the control
(Figure A,B). In addition,
the mRNA levels of p53 and BAX were
not significantly changed (Figure B), suggesting that the mitochondrial apoptotic process
should not be the major regulating mechanism of mTCStoxicity under
low-dose exposure.
Figure 6
Effect of mTCS on the gene expressions related with cell
proliferation
in L02 cells. (A) L02 cell was treated with 0.5, 1, and 5 μM
mTCS for 24 h, and then, the expression of Cyt-c protein
was determined by western blotting. GAPDH protein expression was used
as the internal reference. (B–D) L02 cell was treated with
1 μM mTCS for 12 h, and then, the expression of related genes
was detected with RT-qPCR. (B) Apoptosis related genes. (C) Cell cycle-related
genes. (D) Genes related to AP-1 transcription. *p < 0.05, compared with the control group. (C) Control group: cells
were treated with 0.1% DMSO/DMEM (v/v).
Effect of mTCS on the gene expressions related with cell
proliferation
in L02 cells. (A) L02 cell was treated with 0.5, 1, and 5 μM
mTCS for 24 h, and then, the expression of Cyt-c protein
was determined by western blotting. GAPDH protein expression was used
as the internal reference. (B–D) L02 cell was treated with
1 μM mTCS for 12 h, and then, the expression of related genes
was detected with RT-qPCR. (B) Apoptosis related genes. (C) Cell cycle-related
genes. (D) Genes related to AP-1 transcription. *p < 0.05, compared with the control group. (C) Control group: cells
were treated with 0.1% DMSO/DMEM (v/v).The cell cycle process is also one of the main factors affecting
cell growth. CyclinD1, a cell cycle regulator, regulates transition
of the cell cycle from the G1/G0 phase to the
S phase.[57] P16 is a cyclin-dependent kinase
inhibitor, playing an important role in negative regulation on G1/S transition. Inactivation of p16 was associated with uncontrolled
cell hyperproliferation, which was involved in tumor initiation and
progression.[58] Data of this research showed
that CyclinD1 expression was slightly upregulated,
while p16 expression had a slight downregulated trend,
which is consistent with the results of cell proliferation and migration
(Figure C). However,
neither of these changes is of statistical significance, and the effect
of mTCS on the L02 cell cycle could not be determined.Activating
protein-1 (AP-1) is a dimer transcription factor, including
proto-oncogene Jun and Fos, activating transcription factor (ATF),
and other family members.[59] The AP-1 family
of dimeric transcriptional complexes is involved in almost all cellular
and physiological processes and is implicated in many tumorigenic
processes.[60] Generally, Jun is a positive
regulator of cell proliferation, and aberrant Jun overexpression was
associated with enhanced cell proliferation and malignant transformation.[61,62] Proto-oncogene JunB has an opposite effect to Jun, and downregulated
expression of JunB is found in many tumor cells, which is important
in malignant development and progression.[63] In this study, the expression of Jun was increased
and JunB expression was decreased after 1 μM
mTCS exposure (Figure D). Furthermore, increased Fos expression leads to reversible malignant
hepatocellular transformation, playing a promoting role in early HCC
development.[64] Our data showed that the
expression of FosB (one of the members of Fos) was
significantly increased in both groups (Figure D). These results suggested that the AP-1
activity is involved in the cellular proliferation induced by mTCS.
Conclusions
In summary, this study showed that mTCS had
hormesis effects on
cell proliferation and migration in L02 cells. A low dose of mTCS
promoted the malignant transformation of L02 cells in vitro, as manifested by stimulation of cell proliferation, increased anchor-independent
proliferation, and enhanced cell migration. C-Myc, PCNA, MDM2, and
MMP9 participated in the stimulatory proliferation effect induced
by a low dose of mTCS, while expressions of apoptosis-related and
cell cycle-related genes were not significantly changed after low-dose
mTCS exposure. The different cellular effects of L02 on cell proliferation
and migration after low- and high-dose mTCS exposure may be explained
by different ROS production levels and consequent genomic transcriptional
responses related to cell proliferation. Considering the enhanced
proliferation induced by low-dose mTCS and its environmental persistence,
the carcinogenic potential of mTCS under long-term exposure and the
regulating mechanisms are needed to be evaluated in future in-depth
study.
Materials and Methods
Chemicals and Reagents
The standard
mTCS powder (CAS:
4640-01-1, purity >97%) was purchased from Dr. Ehrensorfer (Germany).
The storage solution of mTCS was dissolved in DMSO to a concentration
of 200 mM, aliquoted, and stored at −20 °C. The fetal
bovine serum (FBS) and DMEM were obtained from Invitrogen (CA, USA).
The reverse transcription kit and SYBR were purchased from TOYOBO
(Osaka, Japan). DMSO, DCFH-DA fluorescent probe, tert-Butyl hydroperoxide (tBHP), RNase A, trypsin, and other analytical
reagents used in this study were obtained from Sigma (MO, USA).
Cell Lines and Culture Conditions
The human L02 hepatocyte
cell line was a gift of Professor Ping-Kun Zhou (Beijing Institute
of Radiation Medicine, Beijing, China). Immortalized L02 cells were
widely used in the toxicity examination of exogenous compounds, since
they have similar proliferation characteristics with normal liver
cells.[65] L02 cells were incubated in DMEM
complete medium containing 10% FBS and 1% penicillin–streptomycin,
maintained in a constant temperature incubator at 37 °C with
5% CO2. When cells continuously grew to 80% confluency,
various concentrations (0.1, 0.5, 1, 5, 10, 20, 40, and 60 μM)
of mTCS were added and coincubated for different times. After treatment,
the cell viability, migration ability, redox status, gene expression
at mRNA, and protein levels were measured. Cells of the control group
were treated with 0.1% DMSO (v/v) only. All experiments were carried
out at least three times with more than three parallel samples.
Analysis of Cell Viability
CCK-8 (Dojindo, Kumamoto,
Japan) was used to determine the cell viability according to the manufacturer’s
instruction. L02 cells were digested with trypsin to prepare cell
suspension (2 × 104 cells/mL), which was then inoculated
in 96-well plates (100 μL/well). After attachment for 24 h,
cells were coincubated with different doses of mTCS for 48 h. The
mTCS concentration gradient was set as low-dose groups (0.1, 0.5,
1, and 5 μM) and high-dose groups (10, 20, 40, and 60 μM).
The control group was treated with DMEM complete medium containing
0.1% DMSO (v/v). The cell viability after mTCS exposure was indirectly
represented by absorbance at 450 nm measured with a multifunction
microplate luminometer (Tecan, Switzerland).
Colony Formation Experiment
Colony formation experiment
is an important method to detect cell proliferation and invasiveness,
and the colony formation rate indicates the independent viability
of cells. In vitro, when a single cell proliferates
for more than six generations (about 10–14 d), the cell population
becomes a clone containing more than 50 cells with a size between
0.3 and 1.0 mm.[66]The long-term survival
of L02 cells exposed to mTCS was monitored by plate cloning assay.
Cell suspensions (300 cells/well) were prepared and seeded in 60 mm
Petri dish, which were then treated with different concentrations
of mTCS (0.1, 0.5, 1, 5, 10, 20, 40, and 60 μM) for 14 d. The
visible cell colonies were fixed with methanol and stained with Giemsa
(Sigma, MO, USA) solution for 15 min. The colony-forming ability of
L02 cells was further evaluated with soft agar clone formation assay,
which was slightly adjusted based on previous experimental procedures.[66] In brief, the 6 g/L lower agarose and 3 g/L
upper agarose containing 150 cells were prepared in a six-well plate.
Cells in soft agar were incubated in a constant temperature incubator
at 37 °C for 14 d. Cell clones were stained with crystal violet
(Sigma, MO, USA). Typical colony images were recorded with a microplate
reader (Olympus, Tokyo, Japan), and the number of cell colonies was
counted.
Wound Healing Assay
Wound healing assay is widely used
to evaluate the migration ability of cells. Briefly, approximately
5 × 105 cells were inoculated in a 24-well plate,
using the overnight monolayer as the standard. Cell scratches in the
plate well were prepared with a 10 μL pipette tip perpendicular.
After washing with phosphate-buffered saline, cells were incubated
with different concentrations of mTCS solution (0.5, 1, 5, and 40 μM)
diluted with serum-free medium for 24 or 48 h. The cell scratches
at the same location in each well were photographed using a microscope
reader (Olympus, Tokyo, Japan). The photographs were analyzed with
ImageJ software to quantify the area of the scratches and relative
healing rate.
Oxidative Stress Detection
The DCFH-DA
fluorescence
probe was used to detect the ROS levels in L02 cells. Once penetrated
into cells, DCFH-DA could be hydrolyzed by esterase to form DCFH,
and then, DCFH could be further oxidized by ROS to form the strong
fluorescent product DCF. The fluorescence intensity of DCF could thus
indirectly reflect the level of ROS in the cell. After exposure to
various concentrations of mTCS (0.1, 0.5, 1, 5, 10, 20, and 40 μM),
cells were incubated with 10 μM DCFH-DA in the dark for 20 min.
In the same time, tBHP was applied as the positive control. The ZOE
fluorescent cell imager (Bio-Rad, CA, USA) was used to take photographs
under the green channel. The fluorescent photographs were analyzed
with Ipwin32 software, and the average fluorescence intensity of different
concentration groups was quantitated.
Western Blotting Analysis
Cells were treated with mTCS
(0.5, 1, and 5 μM) for 24 h, and then, the total protein was
collected and subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. The protein samples were transferred to the polyvinylidene
fluoride membrane (Sigma, MO, USA). The primary and corresponding
secondary antibodies were then incubated with protein samples according
to the manufacturer’s instructions. Finally, blots were visualized
using chemiluminescence, and the optical density of each band was
quantified using the ChemiDoc imaging system (Bio-Rad, CA, USA).Primary antibodies used in this experiment were as follows: anti-MMP9
and anti-Cyt-c antibodies were purchased from Epitomics
(CA, USA), the anti-MDM2 antibody was purchased from Milipore (MA,
USA), and the anti-GAPDH antibody was purchased from Abcam (Cambridgeshire,
UK). The secondary antibodies and anti-mouse immunoglobulin G (IgG)
were purchased from Ding Guo Bio Tech (Beijing, China), and anti-rabbit
IgG was purchased from Zhong Shan Bio Tech (Beijing, China).
RT-qPCR
Assay
After treatment of 0.1% DMSO or 1 μM
mTCS for 12 h, the total RNA of L02 cells was extracted using TRIzol
reagents. The agarose gel electrophoresis image of total RNA is shown
in Figure S1. The qualified RNA samples
were reversely transcribed into cDNA using a reverse transcription
kit (TOYOBO, Osaka, Japan). RT-qPCR reaction was then performed to
detect the expression level of related target genes. The amplification
procedure was started at 95 °C for 60 s and then followed by
50 cycles of denaturation at 95 °C for 15 s, annealing at 63
°C for 15 s, and extension at 72 °C for 45 s. The primer
pairs were purchased from Sunny Biotechnology (Shanghai, China), as
shown in Table . The
ΔΔCt method was used to quantify the gene expression levels
after normalization to the internal reference gene (GAPDH).
Table 1
Primer Sequence for RT-qPCR
gene name
primer
primer sequence (5′–3′)
MW
Tm/0.05 M (°C)
GC %
c-Myc
forward
GGCTCCTGGCAAAAGGTCA
5837.84
60
58
reverse
CTGCGTAGTTGTGCTGATGT
6170.04
55.3
50
MDM2
forward
GAATCATCGGACTCAGGTACATC
7032.64
58
48
reverse
TCTGTCTCACTAATTGCTCTCCT
6891.64
56.21
43
PCNA
forward
CCTGCTGGGATATTAGCTCCA
6397.24
57.59
52
reverse
CAGCGGTAGGTGTCGAAGC
5893.84
62
63
Jun
forward
TCCAAGTGCCGAAAAAGGAAG
6497.24
55.63
48
reverse
CGAGTTCTGAGCTTTCAAGGT
6452.24
55.63
48
JunB
forward
ACGACTCATACACAGCTACGG
6384.24
57.59
52
reverse
GCTCGGTTTCAGGAGTTTGTAGT
7116.64
58
48
FosB
forward
GCTGCAAGATCCCCTACGAAG
6400.24
59.54
57
reverse
ACGAAGAAGTGTACGAAGGGTT
6872.44
55.94
45
Caspase3
forward
CATGGAAGCGAATCAATGGACT
6792.44
55.94
45
reverse
CTGTACCAGACCGAGATGTCA
6415.24
57.59
52
p53
forward
CAGCACATGACGGAGGTTGT
6182.04
57.35
55
reverse
TCATCCAAATACTCCACACGC
6279.24
55.63
48
BAX
forward
CCCGAGAGGTCTTTTTCCGAG
6413.24
59.54
57
reverse
CCAGCCCATGATGGTTCTGAT
6397.24
57.59
52
CyclinD1
forward
GCTGCGAAGTGGAAACCATC
6151.04
57.35
55
reverse
CCTCCTTCTGCACACATTTGAA
6605.44
55.94
45
p16
forward
GATCCAGGTGGGTAGAAGGTC
6551.24
59.54
57
reverse
CCCCTGCAAACTTCGTCCT
5659.84
60
58
GAPDH
forward
GGAGCGAGATCCCTCCAAAAT
6424.24
57.59
52
reverse
GGCTGTTGTCATACTTCTCATGG
7036.64
58
48
Statistical
Analysis
The experimental data were expressed
as the mean ± standard error and analyzed using Excel 2010 software.
The imaging data were processed using ImageJ software. Multiple comparisons
between groups were analyzed using one-way ANOVA with the Bonferroni
post hoc test. The significance of the difference was determined by
the Bonferroni-corrected p-values less than 0.05.
Authors: Lúcia H M L M Santos; Anna Freixa; Sara Insa; Vicenç Acuña; Josep Sanchís; Marinella Farré; Sergi Sabater; Damià Barceló; Sara Rodríguez-Mozaz Journal: Environ Res Date: 2018-11-27 Impact factor: 6.498
Authors: Wei Qu; Bhalchandra A Diwan; Jeffrey M Reece; Carl D Bortner; Jingbo Pi; Jie Liu; Michael P Waalkes Journal: Int J Cancer Date: 2005-04-10 Impact factor: 7.396